Nielsen Kirk G. — SEC Form 4 filings
SEC reporting owner CIK 1523522. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-06 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 528,779 shares, $6,317,142 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: purchase of 165,000 shares @ $16.00 ($2,640,000) in SpyGlass Pharma, Inc., filed 2026-02-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | Director | 4 | 2 legs · 330,000 sh · $5,280,000 | — | 21 |
| CVRx, Inc. (CVRX) | Director | 6 | 4 legs · 198,779 sh · $1,037,142 | — | 5 |
Form 4 filings — Nielsen Kirk G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-03 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4/A | SpyGlass Pharma, Inc. (SGP) | Conversion (C): 1,690,230 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 359,255 (derivative) | EDGAR |
| 2026-02-10 | 4 | SpyGlass Pharma, Inc. (SGP) jointly with Vensana Capital I GP, LLC, Vensana Capital I, L.P., Klein Peter Justin | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-10 | 4 | SpyGlass Pharma, Inc. (SGP) | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-09 | 4 | SpyGlass Pharma, Inc. (SGP) | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 10,966 @ $5.45 | EDGAR |
| 2025-05-14 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 25,200 @ $4.79 · Purchase (P): 101,413 @ $5.29 · Purchase (P): 61,200 @ $5.23 | EDGAR |
| 2024-06-07 | 4/A | CVRx, Inc. (CVRX) | Grant/award (A): 27,250 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 20,961 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1523522 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →